Which indicators should be tracked to analyze clinical trials?
Key indicators to track include the number of trials by therapeutic phase, patient recruitment rates, enrollment timelines, cost per patient, active investigator sites, regulatory milestones, dropout rates, CRO partnerships, interim results and delay risks. These data points help assess pipeline robustness, operational feasibility and opportunities for pharmaceutical companies, biotechs, CROs and investors.